Rachel brings more than ten years of scientific and consulting expertise to Bionest and its clients. She has been with Bionest since 2010, first in the New York office and now in Basel, Switzerland.
Rachel supports pharma, biotech, and diagnostic companies on strategic assignments encompassing new product planning and go-to-market strategy. She collaborates with her clients to foster creative and innovative thinking, drive cross-functional alignment, and deliver pragmatic and actionable solutions to help grow and develop the business.
Rachel has a specific expertise in and passion for oncology and diagnostics, owing to her scientific background. She leads the Oncology and Precision Medicine practices at Bionest and is a recognized thought leader in the space.
Prior to joining Bionest, Rachel completed a Ph.D. at the University of California, Los Angeles, where her work focused on immuno-oncology and non-invasive imaging biomarkers. Rachel also holds an M.S. in Neuropharmacology from the University of Oxford and a B.S. in Molecular and Cell Biology from UCLA.